Page last updated: 2024-10-21

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Opioid-Related Disorders

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with Opioid-Related Disorders in 1 studies

1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one : A member of the class of oxadiazoloquinoxalines that is 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline substituted at position 1 by an oxo group.

Opioid-Related Disorders: Disorders related to or resulting from abuse or misuse of OPIOIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sullivan, ME1
Hall, SR1
Milne, B1
Jhamandas, K1

Other Studies

1 other study available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Opioid-Related Disorders

ArticleYear
Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Brain research, 2000, Mar-17, Volume: 859, Issue:1

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Cyclic GMP; Enzyme Inhibitors; Excitatory Amino Acids

2000